Skip to content

Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Nabi Sends Letter to Stockholders Responding to Mangrove's Statements and Calls on Stockholders to Vote Their White Proxy Card Today
Nabi Sends Letter to Stockholders Responding to Mangrove's Statements and Calls on Stockholders to Vote Their White Proxy Card Today ROCKVILLE, Md., Aug. 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that it is sending a letter to its stockholders, a copy of
View HTML
Toggle Summary M Navigator: Deal pipeline - 23 August
M Navigator: Deal pipeline - 23 August Z:M Navigator-August23, 2012-M Navigator: Deal pipeline - 23 August © 2012 M2 COMMUNICATIONS http://www.m2.com The following is a list of deals covered in detail by M Navigator this week: - MORGAN STANLEY INFRASTRUCTURE ARM TO BUY OUT SOUTHERN STAR Morgan
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results ROCKVILLE, Md., Aug. 9, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its second quarter financial results for the three-month period ended June 30, 2012.
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results Release Date
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results Release Date ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its second quarter 2012 financial results on Thursday, August 9, after the market close.
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Final Results of Its Self-Tender Offer
Nabi Biopharmaceuticals Announces Final Results of Its Self-Tender Offer ROCKVILLE, Md., Aug. 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the " Company ") today announced the final results of its "modified Dutch auction" tender offer, which expired at 12:00 midnight, at the
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Preliminary Results of Its Self-Tender Offer
Nabi Biopharmaceuticals Announces Preliminary Results of Its Self-Tender Offer ROCKVILLE, Md., July 31, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the " Company ") today announced the preliminary results of its "modified Dutch auction" tender offer, which expired at 12:00
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Waiver of Cash Reserve Tender Offer Condition
Nabi Biopharmaceuticals Announces Waiver of Cash Reserve Tender Offer Condition ROCKVILLE, Md., July 19, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the " Company ") announced today, in connection with its previously announced tender offer (for up to $23 million in value of its
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Commencement of Self-Tender Offer for Up To $23,000,000 of Its Common Stock
Nabi Biopharmaceuticals Announces Commencement of Self-Tender Offer for Up To $23,000,000 of Its Common Stock ROCKVILLE, Md., July 2, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) (the " Company ") today announced that it is commencing a "modified Dutch auction" tender offer for up
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results
Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results ROCKVILLE, Md., May 10, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three-month period ended March 31, 2011.
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results Release Date
Nabi Biopharmaceuticals Announces First Quarter 2012 Financial Results Release Date ROCKVILLE, Md., May 3, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its first quarter 2012 financial results on Thursday, May 10, 2012, after the market close.
View HTML
Toggle Summary Deal snapshot: AUSTRALIAN BIOTA TO MOVE TO US VIA COMBINATION WITH NABI
Deal snapshot: AUSTRALIAN BIOTA TO MOVE TO US VIA COMBINATION WITH NABI Z:M Navigator-April24, 2012-Deal snapshot: AUSTRALIAN BIOTA TO MOVE TO US VIA COMBINATION WITH NABI © 2012 M2 COMMUNICATIONS http://www.m2.com Australian influenza antivirals developer Biota Holdings Ltd (ASX:BTA) will take
View HTML
Toggle Summary Biota and Nabi Announce Proposed Merger
Biota and Nabi Announce Proposed Merger http://media.marketwire.com/attachments/201010/653964_BIOTA_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=877594&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA -- (Marketwire) -- 04/23/12 -- Biota Holdings Limited (ASX:
View HTML
Toggle Summary M Navigator: Deal pipeline - 23 April
M Navigator: Deal pipeline - 23 April Z:M Navigator-April23, 2012-M Navigator: Deal pipeline - 23 April © 2012 M2 COMMUNICATIONS http://www.m2.com The following is a list of deals covered in detail by M Navigator this week: - SUFF SIGNS LOI FOR CONTROL OF MOBILE APPS DEVELOPER US-based Suff
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Definitive Merger Agreement With Biota Holdings Limited
Nabi Biopharmaceuticals Announces Definitive Merger Agreement With Biota Holdings Limited ROCKVILLE, Md., April 23, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced plans to merge with Biota Holdings Limited (ASX:BTA), a Melbourne, Australia company.
View HTML
Toggle Summary Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2011 Financial Results
Nabi Biopharmaceuticals Announces Fourth Quarter and Full-Year 2011 Financial Results ROCKVILLE, Md., March 14, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended December 31,
View HTML

Log In

Create an account